Dividend stocks provide investors with reliable passive income. These four health care picks look like outstanding ideas now.

NSE analyzed JPL trades, flagged patterns suggesting insider trading based on UPSI deemed price-sensitive, leading to action.

After six straight quarters in which Eli Lilly or Novo Nordisk achieved the highest year-over-year revenue growth among the ...

Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Investors ...

Pfizer Inc. (NYSE:PFE – Free Report ... and potential future mRNA and antiviral products under the Comirnaty and Paxlovid ...

Chris Boshoff will take on the role of chief scientific officer starting Jan 1 & oversee all functions of research & ...

With family gatherings for the holidays approaching along with the beginning of the ski season, this is the time for ...

If you can reach your physician within 48 hours of diagnosis, early prescriptive treatment with Paxlovid can be helpful in ...

Pfizer's stock appears undervalued with a high dividend yield of 6.8%, making it a potential long-term investment despite low growth expectations. The company reported strong Q3 results with 31.2% YoY ...

"Dr Boshoff is the ideal leader to propel Pfizer's R&D engine forward and transform it into a world-leading organisation with ...

As for his soon-to-be former role, Boshoff will be succeeded by Dr. Roger Dansey, who will serve as the interim chief ...

Yet again this winter, millions of Americans will wonder if a nagging cough or body aches is a sign they’re coming down with COVID-19 or the flu. This time, they’ll have an expanded array of tools to ...